Samuel Olson, PhD’s Post

View profile for Samuel Olson, PhD, graphic

Field Application Scientist II at Quanterix | Ultrasensitive Biomarkers Specialist | Client Relation Expertise | RNA Targeting Leader

Curious about the LucentAD test? The p-tau level measured in the results are compared to the clinical cutoff for #Alzheimers pathology likelihood. Healthcare providers can walk patients through their report, answer questions, and discuss next steps. #LucentAD

  • Lucent Diagnostics

To view or add a comment, sign in

Explore topics